Med vs Thrombosis

The Med-HF App supports healthcare professionals in the initiation, titration, assessment and monitoring of 6 drug classes commonly used to treat heart failure: ACEIs/ARBs, Beta-Blockers, MRA: Mineralocorticoid Receptor Antagonist, ARNI: Angiotensin Receptor Blocker / Neprilysin Inhibitor, Ivabradine, Diuretics. This App interactively walks healthcare professionals through evidence-based algorithms, specific to these 6 drug classes, and recommends appropriate actions and considerations based on 2018 Canadian Cardiovascular Society Heart Failure Guidelines. Features: • Recommendations for medication initiation, titration, assessment and monitoring • Dosing information • References • Clinical pearls • General approach and drug class algorithms

The Thrombosis Canada mobile app is your on-the-go resource for up-to-date clinical tools and practice guidelines related to thrombosis management. Built for healthcare professionals, this app offers quick access to: - Clinical Tools: Interactive tools designed to help with diagnosis, treatment, and risk assessment in managing patients with thrombosis. - Clinical Guides: Comprehensive guidelines from Thrombosis Canada covering various thrombosis conditions, treatments, and best practices. - Patient Resources: A wide range of materials including documents and videos, that can be shared with patients to educate them. Key Features: Whether you’re in the clinic, hospital, or consulting remotely, the Thrombosis Canada app ensures you have critical information at your fingertips. - User-Friendly Interface: Navigate easily through tools and guidelines with a simple and intuitive layout. Designed to be robust, yet concise enough to be applicable at the point of care. - Regular Updates: Always stay current with the latest guidelines and evidence-based practices. - Offline Access: Use clinical guides even without an internet connection. - Tailored for Healthcare Professionals: Developed voluntarily by Thrombosis CanadaTM members, internationally recognized as experts and peer reviewed by Thrombosis Canada committee. - Credibility: Reviewed for applicability to primary care by members of the College of Family Physicians of Canada and these were not supported financially by any external funders.